Peptides & Elephants is a German company dedicated to the production of high-quality peptide products. Founded in 2001 and headquartered in Hennigsdorf, Germany, the company provides comprehensive peptide and peptidomimetic solutions. Its capabilities span from single peptides to million-scale peptide libraries, from linear chains to cyclic structures, from short peptides to ultra-long sequences, from crude peptides to high-purity refined peptides, and from modified to labeled peptides, including both natural amino acids and non-natural variants.Peptides & Elephants supports a wide range of research applications, including neoantigen screening, adoptive immunotherapy, T-cell stimulation assays, epitope mapping, ELISpot assays, drug discovery, and peptide microarray technologies.
Vicbio Biotechnology Co., Ltd. provides the full range of Peptides & Elephants products.
⇨ Inquire or Order immediately ⇦
Beyond peptide manufacturing, the company has also independently developed core equipment for peptide synthesis—peptide synthesis robots. Leveraging its patented Ultrasonic Peptide Synthesis Platform (USPS®), the team can efficiently produce hundreds of peptides within a short time while precisely implementing diverse modifications required by customers.
Its core business areas include:
•Catalog peptide supply (ready-to-ship peptides)
•Custom peptide synthesis
•Personalized peptide pool construction
•High-troughput peptide library development
•Peptide microarray preparation services
•Functional modified peptide production
•Precision pre-aliquoted peptide services
| Product Name | Cat. # | Size |
| AAV VP1 492-500 (HLA-A*01:01) | EP11452_1 | 1 mg; 5 mg |
| ADV hexon (HLA-B*35:01) | EP07882_1 | 1 mg; 5 mg |
| ADV hexon 114 -124 (HLA-B*07:02) | EP07881_1 | 1 mg; 5 mg |
| ADV hexon 316-330 (HLA-A*03:01) (HLA-B*35:01) | EP12201_1 | 1 mg; 5 mg |
| ADV hexon 37-45 (HLA-A*24:02) | EP07880_1 | 1 mg; 5 mg |
| ADV hexon 886-894 (HLA-A*01:01) | EP10774_1 | 1 mg; 5 mg |
| ADV Hexon 917-925 (HLA-A*02:01) | EP07914_1 | 1 mg; 5 mg |
| Alpha Variant B.1.1.7 SCoV2 (Spike Glycoprotein) Peptide Pool | LB01944 | 15 nmol/peptide |
| B8R 20-27 (H-2 Kb) | EP08851_1 | 1 mg; 5 mg |
| BA.4/BA.5 Omicron full length SCoV2 (Spike Glycoprotein) Peptide Pool | LB02055 | 15 nmol/peptide |
| Beta Variant B.1.351 SCoV2 (Spike Glycoprotein) Peptide Pool | LB01945 | 15 nmol/peptide |
| BKV (BK-Virus LT) Peptide Pool | LB01687 | 15 nmol/peptide |
| BKV Large T antigen 579-587 (HLA-A*02:01) | EP11093_1 | 1 mg; 5 mg |
| BKV Large T antigen 406-414 (HLA-A*02:01) | EP11094_1 | 1 mg; 5 mg |
| BKV VP1 108-116 (HLA-A*02:01) | EP11456_1 | 1 mg; 5 mg |
| BKV VP1 Peptide Pool | LB01967 | 15 nmol/peptide |
| Candida (MP65) Peptide Pool | LB01813 | 15 nmol/peptide |
| Candidapepsin-5 Peptide Pool | LB01979 | 15 nmol/peptide |
| CEF (classic) Peptide Pool (>95% HPLC) | LB01358 | 15 nmol/peptide |
| CEF control Peptide Pool (>95% HPLC, advanced) | LB01359 | 15 nmol/peptide |
| Chlamydia trachomatis MOMP 258-266 (HLA-A*02:01) | EP11114_1 | 1 mg; 5 mg |
| CMV Sub Peptide Pool (>95% HPLC) | LB01713 | 15 nmol/peptide |
| crf1 Peptide Pool | LB01814 | 15 nmol/peptide |
| Delta Variant B.1.617.2 SCoV2 (Spike Glycoprotein) Peptide Pool | LB01947 | 15 nmol/peptide |
| Delta Variant B.1.617.2 SCoV2 wt (Spike Glycoprotein) Peptide Pool | LB02018 | 15 nmol/peptide |
| EBNA-1 Protein (562-570) | EP04510_1 | 1 mg; 5 mg |
| EBV BMLF-1 280-288 (HLA-A*02:01) | EP07604_1 | 1 mg; 5 mg |
| EBV BZLF-1 190-197 (HLA-B*08:01) | EP07899_1 | 1 mg; 5 mg |
| EBV EBNA-3A 379-387 (HLA-B*07:02) | EP05817_1 | 1 mg; 5 mg |
| EBV EBNA-3A 603-611 (HLA-A*03:01) | EP07892_1 | 1 mg; 5 mg |
| EBV LMP2 131-139 (HLA-A*24:02) | EP05807_1 | 1 mg; 5 mg |
| EBV LMP2 356-364 (HLA-A*02:01) | EP07893_1 | 1 mg; 5 mg |
| Elongation factor 2 Peptide Pool | LB01928 | 15 nmol/peptide |
| Env 345-359 | EP12426_1 | 1 mg; 5 mg |
| Env 57-71 | EP12425_1 | 1 mg; 5 mg |
| Epsilon Variant B.1.427/B.1.429 SCoV2 (Spike Glycoprotein) Peptide Pool | LB01951 | 15 nmol/peptide |
| ESAT6 50-58 (HLA-A*24:02) | EP11165_1 | 1 mg; 5 mg |
| Eta Variant B.1.525 SCoV2 (Spike Glycoprotein) Peptide Pool | LB01953 | 15 nmol/peptide |
| f22 Peptide Pool | LB01815 | 15 nmol/peptide |
| fn20 env 122-141 | EP14428_1 | 1 mg; 5 mg |
| Gamma Variant P.1 SCoV2 (Spike Glycoprotein) Peptide Pool | LB01946 | 15 nmol/peptide |
| H250 (HLA-A*02:01) | EP11186_1 | 1 mg; 5 mg |
| HBV core 18-27 (HLA-A*02:01) | EP07857_1 | 1 mg; 5 mg |
| HBV_Polymerase_171 | EP10273_1 | 1 mg; 5 mg |
| HBVcore14, (HBA31) | EP10272_1 | 1 mg |
| HCMV IE-1 199-207 (HLA-B*08:01) | EP11120_1 | 1 mg; 5 mg |
| HCMV IE-1 199-207 mutant (HLA-B*08:01) 201K, 205I | EP11118_1 | 1 mg; 5 mg |
| HCMV IE-1 248-256 (HLA-A*24:02) | EP11117_1 | 1 mg; 5 mg |
| HCMV IE-1 316-324 (HLA-A*02:01) | EP05820_1 | 1 mg |
| HCMV IE-1 378-389 (HLA-B18) | EP08624_1 | 1 mg; 5 mg |
| HCMV IE-1 88-96 (HLA-B*08:01) | EP10116_1 | 1 mg; 5 mg |
| HCMV IE1 162-173 (HLA-DRB1*0801) | EP20305_1 | 1 mg; 5 mg |
| HCMV IE1 184-192 (HLA-A*03:01) | EP11116_1 | 1 mg; 5 mg |
| HCMV IE1 51-59 (HLA-B*08:01) | EP11119_1 | 1 mg; 5 mg |
| HCMV IE1 81-89 (HLA-A*02:01) | EP11197_1 | 1 mg; 5 mg |
| HCMV pp50 245-253 (HLA-A*01:01) | EP05819_1 | 1 mg; 5 mg |
| HCMV pp65 113-121 (HLA-A*24:02) | EP11121_1 | 1 mg; 5 mg |
| HCMV pp65 123-131 (HLA-B*35:01) | EP11122_1 | 1 mg; 5 mg |
| HCMV pp65 16-24 (HLA-A*11:01) | EP06165_1 | 1 mg; 5 mg |
| HCMV pp65 265-275 (HLA-B*07:02) | EP07911_1 | 1 mg; 5 mg |
| HCMV pp65 341-349 (HLA-A*24:02/HLA-A*23:01) | EP07900_1 | 1 mg; 5 mg |
| HCMV pp65 363-373 (HLA-A*01:01) | EP11198_1 | 1 mg; 5 mg |
| HCMV pp65 417 – 426 (HLA-B*07:02) | EP05818_1 | 1 mg; 5 mg |
| HCMV pp65 495-503 (HLA-A*02:01) | EP04509_1 | 1 mg |
| HCMV pp65 512-521 (HLA-B*44:02) | EP11484_1 | 1 mg; 5 mg |
| HCMV UL138 (HLA-B*35:01) | EP11123_1 | 1 mg; 5 mg |
| HCMV UL40 15-23 (HLA-E) | EP06244_1 | 1 mg; 5 mg |
| HCMVA (IE1) Peptide Pool | LB01854 | 15 nmol/peptide |
| HCMVA (IE2) Peptide Pool | LB01853 | 15 nmol/peptide |
| HCMVA (pp65) Peptide Pool | LB02024 | 15 nmol/peptide |
| HCMVlfl | EP08069_1 | 1 mg; 5 mg |
| HCMVos | EP04776_1 | 1 mg; 5 mg |
| HCoV-229E (Spike Glycoprotein) Peptide Pool | LB01783 | 15 nmol/peptide |
| HCoV-229E Membrane protein M Peptide Pool | LB01842 | 15 nmol/peptide |
| HCoV-229E Nucleoprotein N Peptide Pool | LB01841 | 15 nmol/peptide |
| HCoV-HKU1 (isolate N5) Membrane protein M Peptide Pool | LB01844 | 15 nmol/peptide |
| HCoV-HKU1 (isolate N5) Nucleoprotein N Peptide Pool | LB01843 | 15 nmol/peptide |
| HCoV-NL63 Membrane protein M Peptide Pool | LB01846 | 15 nmol/peptide |
| HCoV-NL63 Nucleoprotein N Peptide Pool | LB01845 | 15 nmol/peptide |
| HCoV-OC43 (Spike Glycoprotein) Peptide Pool | LB01784 | 15 nmol/peptide |
| HCoV-OC43 Membrane protein M Peptide Pool | LB01848 | 15 nmol/peptide |
| HCoV-OC43 Nucleoprotein N Peptide Pool | LB01847 | 15 nmol/peptide |
| HCV (gt. 1b, isol. BK) NS3 1406-1415 (HLA-A*02:01) | EP11206_1 | 1 mg; 5 mg |
| HCV (gt. 1b, isol. Con1) NS3 1406-1415 (HLA-A*02:01) | EP08800_1 | 1 mg; 5 mg |
| HCV 2416-2424 (HLA-A26) | EP11907_1 | 1 mg; 5 mg |
| HCV core 111-119 (HLA-B*07:02) | EP11202_1 | 1 mg; 5 mg |
| HCV core 132-140 (HLA-A*02:01) | EP11199_1 | 1 mg; 5 mg |
| HCV core 132-140 mutant (HLA-A*02:01) 139L | EP11200_1 | 1 mg; 5 mg |
| HCV core 35-44 (HLA-A*02:01) | EP11201_1 | 1 mg; 5 mg |
| HCV core 41-49 (HLA-B*07:02) | EP11203_1 | 1 mg; 5 mg |
| HCV E1 207-214 (HLA-B*35:01) | EP11204_1 | 1 mg; 5 mg |
| HCV NS3 1031-1039 (HLA-A*24:02) | EP11207_1 | 1 mg; 5 mg |
| HCV NS3 1073-1081 (HLA-A*02:01) | EP11371_1 | 1 mg; 5 mg |
| HCV NS3 1073-1081 mutant (HLA-A*02:01) 1074V | EP11222_1 | 1 mg; 5 mg |
| HCV NS3 1267-1275 | EP14013_1 | 1 mg |
| HCV NS3 1359-1367 (HLA-B*35:01) | EP11208_1 | 1 mg; 5 mg |
| HCV NS3 1373–1380 (HLA-B*51:01) | EP11230_1 | 1 mg |
| HCV NS3 1395-1403 (HLA-B*08:01) | EP11226_1 | 1 mg; 5 mg |
| HCV NS3 1406-1415 (HLA-A*02:01) | EP07916_1 | 1 mg; 5 mg |
| HCV NS3 1436-1444 (HLA-A*01:01) | EP11205_1 | 1 mg; 5 mg |
| HCV NS3 1436-1444 mutant (HLA-A*01:01) 1444Y | EP11221_1 | 1 mg; 5 mg |
| HCV NS4A 1635-1643 (HLA-A*03:01) | EP11225_1 | 1 mg; 5 mg |
| HCV NS4B 214-222 (HLA-A*02:01) | EP11224_1 | 1 mg; 5 mg |
| HCV NS5 672-680 (B*07:02) | EP14494_1 | 1 mg; 5 mg |
| HCV NS5a 1992-2200 (HLA-A*02:01) | EP11217_1 | 1 mg; 5 mg |
| HCV NS5a 2266-2275 (HLA-B*40:01) | EP11218_1 | 1 mg; 5 mg |
| HCV NS5B 2588-2596 (HLA-A*03:01) | EP11220_1 | 1 mg; 5 mg |
| HCV NS5B 2594-2602 (HLA-A*02:01) | EP08801_1 | 1 mg; 5 mg |
| HCV NS5b 2594-2602 mutant (HLA-A*02:01) 2600S | EP09830_1 | 1 mg; 5 mg |
| HCV NS5B 2727-2735 (HLA-A*02:01) | EP11219_1 | 1 mg; 5 mg |
| HCV Polyprotein 1273-1282 (HLA-A*02:01) | EP11223_1 | 1 mg; 5 mg |
| HCV Sub Peptide Pool (>95% HPLC) | LB01717 | 15 nmol/peptide |
| HDV 192-200 | EP12464_1 | 1 mg; 5 mg |
| HDV 194-202 | EP12465_1 | 1 mg; 5 mg |
| HDV 46-54 | EP14012_1 | 1 mg; 5 mg |
| HHV-8 gB 492-500 (HLA-A*02:01) | EP11236_1 | 1 mg; 5 mg |
| HHV1 Envelope Glycoprotein D Peptide Pool | LB01816 | 15 nmol/peptide |
| HHV5 UL44 Peptide Pool | LB01958 | 15 nmol/peptide |
| HHV6 (U54) Peptide Pool | LB01697 | 15 nmol/peptide |
| HHV6 (U90) Peptide Pool | LB01698 | 15 nmol/peptide |
| HHV8 (K8.1) Peptide Pool | LB01700 | 15 nmol/peptide |
| HHV8 (K8) Peptide Pool | LB01699 | 15 nmol/peptide |
| HHV8 K6 Peptide Pool | LB02063 | 15 nmol/peptide |
| HHV8 ND 17-25 (HLA-A*02:01) | EP11239_1 | 1 mg; 5 mg |
| HHV8 NP 69-77 (HLA-A*02:01) | EP11240_1 | 1 mg; 5 mg |
| HIV control Peptide Pool (95% HPLC) | LB01718 | 15 nmol/peptide |
| HIV env 216-224 (HLA-A*29:02) | EP11246_1 | 1 mg; 5 mg |
| HIV Env 314–322 (HLA-B*27:05) | EP11249_1 | 1 mg; 5 mg |
| HIV env 382-391 (HLA-A*29:02) | EP11247_1 | 1 mg |
| HIV env 584–592 (HLA-A*24:02) | EP11245_1 | 1 mg; 5 mg |
| HIV Env 586-593 (HLA-B*08:01) | EP12117_1 | 1 mg; 5 mg |
| HIV env 816-825 (HLA-A*02:01) | EP11243_1 | 1 mg; 5 mg |
| HIV Env gp 67-75 (HLA-A*02:01) | EP11242_1 | 1 mg; 5 mg |
| HIV Env gp160 585-593 (HLA-A*24:02) | EP11244_1 | 1 mg; 5 mg |
| HIV Gag 150-158 (HLA-A*02:01) | EP11251_1 | 1 mg; 5 mg |
| HIV gag 197-205 (H-2 Kd) | EP07874_1 | 1 mg; 5 mg |
| HIV Gag 433-440 (HLA-A*02:01) | EP11250_1 | 1 mg; 5 mg |
| HIV Gag 50-59 (HLA-A*02:01) | EP11253_1 | 1 mg; 5 mg |
| HIV Gag 77-85 (HLA-A*02:01) | EP11252_1 | 1 mg; 5 mg |
| HIV gag 79-86 (HLA-A*29:02) | EP11257_1 | 1 mg; 5 mg |
| HIV gag p17 28-36 (HLA-A*24) | EP14868_1 | 1 mg; 5 mg |
| HIV gag p24 128-135 (HLA-B*08:01) | EP14866_1 | 1 mg; 5 mg |
| HIV Gag p24 128-136 (HLA-B*08:01) | EP11258_1 | 1 mg; 5 mg |
| HIV gag p24 223–231 (HLA-B*07:02) | EP11261_1 | 1 mg; 5 mg |
| HIV nef 131-140 (HLA-A*24:02) | EP11264_1 | 1 mg; 5 mg |
| HIV nef 84-92 (HLA-A*11:01) | EP11263_1 | 1 mg; 5 mg |
| HIV p24 gag 176-184 mutant (HLA-B*53:01) 183G | EP14865_1 | 1 mg; 5 mg |
| HIV p24-Gag 263-272 (HLA-B*27:05) | EP07894_1 | 1 mg; 5 mg |
| HIV p24-Gag 30-40 (HLA-B*57:01) | EP07895_1 | 1 mg; 5 mg |
| HIV Pol (HLA-A*02:01) | EP11267_1 | 1 mg; 5 mg |
| HIV Pol 606–614 (HLA-A*02:01) | EP11266_1 | 1 mg; 5 mg |
| HIV Vif 23-31 (HLA-A*02:01) | EP11268_1 | 1 mg; 5 mg |
| HIV Vpu 66-74 (HLA-A*02:01) | EP11270_1 | 1 mg; 5 mg |
| HIV-1 B Gag Peptide Pool | LB02118 | 15 nmol/peptide |
| HIV-1 env gp120 843–851 (HLA-B*07:02) | EP11272_1 | 1 mg; 5 mg |
| HIV-1 env gp120 90-98 (HLA-A*02:01) | EP11271_1 | 1 mg |
| HIV-1 gag p17 20-28 (HLA-A*03:01) | EP11256_1 | 1 mg; 5 mg |
| HIV-1 gag p24 19-27 (HLA-A*02:01) | EP11255_1 | 1 mg; 5 mg |
| HIV-1 gag p24 261-269 (HLA-B*08:01) | EP11275_1 | 1 mg; 5 mg |
| HIV-1 Gag p24 263-272 (HLA-B*27:05) | EP11276_1 | 1 mg; 5 mg |
| HIV-1 nef 128-137 (HLA-B*07:02) | EP11265_1 | 1 mg; 5 mg |
| HIV-1 Nef 134-143 (HLA-A*24:02) | EP11278_1 | 1 mg; 5 mg |
| HIV-1 Nef 137-145 (HLA-A*02:01) | EP11277_1 | 1 mg; 5 mg |
| HIV-1 nef 73-82 (HLA-A*03:01) | EP11262_1 | 1 mg; 5 mg |
| HIV-1 nef 90-97 (HLA-B*08:01) | EP11279_1 | 1 mg; 5 mg |
| HIV-1 Nef 92-100 (HLA-B*40:01) | EP11280_1 | 1 mg; 5 mg |
| HIV-1 p17 20-29 (HLA-B*15:01) | EP11281_1 | 1 mg; 5 mg |
| HIV-1 p17 Gag 77-85 (HLA-A*02:01) | EP07855_1 | 1 mg; 5 mg |
| HIV-1 p17 Gag 77-86 (HLA-A*02:01) | EP11254_1 | 1 mg; 5 mg |
| HIV-1 RT 273-282 (HLA-B*35:01) | EP11415_1 | 1 mg; 5 mg |
| HIV-1 RT 330-338 (HLA-B*35:01) | EP11282_1 | 1 mg; 5 mg |
| HIV-1 RT 476-484 (HLA-A*02:01) | EP08035_1 | 1 mg; 5 mg |
| HIV-1 Vif 101-109 (HLA-A*02:01) | EP11269_1 | 1 mg; 5 mg |
| HIV-2 gag 260-269 (HLA-B*27:05) | EP11260_1 | 1 mg; 5 mg |
| HLA-A2 140-149 (HLA-A*02:01) | EP11284_1 | 1 mg; 5 mg |
| HPV 11 E7 81-89 (HLA-A*02:01) | EP12202_1 | 1 mg; 5 mg |
| HPV 16 E2 69–77 (HLA-A*02:01) | EP12203_1 | 1 mg; 5 mg |
| HPV 16 E6 29-38 (HLA-A*02:01) | EP08803_1 | 1 mg; 5 mg |
| HPV 16 E6 48-57 (H-2 Kb) | EP10707_1 | 1 mg; 5 mg |
| HPV 16 E6 52-61 (HLA-B*35:01) | EP12208_1 | 1 mg; 5 mg |
| HPV 16 E6 64-72 (HLA-A*03:01) | EP11289_1 | 1 mg; 5 mg |
| HPV 16 E6 86-94 (HLA-A*11:01) | EP11290_1 | 1 mg; 5 mg |
| HPV 16 E6 Peptide Pool | LB02048 | 15 nmol/peptide |
| HPV 16 E7 5-13 (HLA-B*07:02) | EP11294_1 | 1 mg; 5 mg |
| HPV 16/18 E6 133–142 (HLA-A*68:01) | EP14313_1 | 1 mg; 5 mg |
| HPV 16/18 E6 31-38 (HLA-B*40:02) | EP14315_1 | 1 mg; 5 mg |
| HPV 16/18 E6 75-83 (HLA-A*24:02) | EP12206_1 | 1 mg; 5 mg |
| HPV 16/18 E6 87-95 (HLA-A*24:02) | EP12205_1 | 1 mg; 5 mg |
| HPV 16/18 E7 11-19 (HLA-A*02:01) | EP06817_1 | 1 mg; 5 mg |
| HPV 16/18 E7 11-20 (HLA-A*02:01) | EP11293_1 | 1 mg; 5 mg |
| HPV 16/18 E7 12-20 (HLA-A*02:01) | EP11292_1 | 1 mg; 5 mg |
| HPV 16/18 E7 49-57 (H-2 Db) | EP07741_1 | 1 mg; 5 mg |
| HPV 16/18 E7 88-97 (HLA-A*11) | EP14314_1 | 1 mg; 5 mg |
| HPV 18 E6 Peptide Pool | LB02476 | 15 nmol/peptide |
| HPV L1 296-304 (HLA-A*11) | EP12207_1 | 1 mg; 5 mg |
| HPV Sub Peptide Pool (>95% HPLC) | LB01719 | 15 nmol/peptide |
| HPV16 (L1) Peptide Pool | LB02038 | 15 nmol/peptide |
| HPV16 (L2) Peptide Pool | LB02040 | 15 nmol/peptide |
| HPV16 E2 Peptide Pool | LB02472 | 15 nmol/peptide |
| HPV16 E5 Peptide Pool | LB02473 | 15 nmol/peptide |
| HPV16 E7 Peptide Pool | LB02047 | 15 nmol/peptide |
| HPV16 L1 349-357 (HLA-A*02:01) | EP12204_1 | 1 mg; 5 mg |
| HPV18 (L1) Peptide Pool | LB02039 | 15 nmol/peptide |
| HPV18 (L2) Peptide Pool | LB02041 | 15 nmol/peptide |
| HPV18 E2 Peptide Pool | LB02474 | 15 nmol/peptide |
| HPV18 E5 Peptide Pool | LB02475 | 15 nmol/peptide |
| HPV18 E7 Peptide Pool | LB02477 | 15 nmol/peptide |
| HTLV Tax 11-19 (HLA-A*02:01) | EP11300_1 | 1 mg; 5 mg |
| HTLV Tax 301-309 (HLA-A*24:02) | EP11301_1 | 1 mg; 5 mg |
| HTLV-1 (TAX) Peptide Pool | LB01701 | 15 nmol/peptide |
| HTLV-1 basic zipper factor (HBZ_HTL1A) Peptide Pool | LB02072 | 15 nmol/peptide |
| Human adenovirus 5 542-550 (HLA-A*02:02) | EP12479_1 | 1 mg; 5 mg |
| Human HLA-A*02, A*24 leader 3-11 (HLA-A*02) | EP09213_1 | 1 mg; 5 mg |
| Hyphally regulated cell wall protein 1 Peptide Pool | LB01934 | 15 nmol/peptide |
| IDO199-207 (HLA-A*02:01) | EP11307_1 | 1 mg; 5 mg |
| IE-1 316-324 (HLA-A*02:01) | EP06999_1 | 1 mg; 5 mg |
| IE-1 99-107 (HLA-A*03:01) | EP06998_1 | 1 mg; 5 mg |
| IE62 (HLA-A*02:01) | EP11308_1 | 1 mg; 5 mg |
| IE62 593-601 (HLA-A*02:01) | EP14274_1 | 1 mg; 5 mg |
| IFNB1 Peptide Pool | LB02001 | 15 nmol/peptide |
| Influenza A (H1N1) HA Peptide Pool | LB01817 | 15 nmol/peptide |
| Influenza A (PR8) NP 265-274 (HLA-A*03:01) | EP11313_1 | 1 mg; 5 mg |
| Influenza A M1 125–132 (HLA-B27) (HLA-B35) | EP11480_1 | 1 mg; 5 mg |
| Influenza A M1 13-21 (HLA-A*11:01)(HLA-A*03:01)(HLA-A*31:01)(HLA-A*68:01) | EP11314_1 | 1 mg; 5 mg |
| Influenza A M1 178-187 (HLA-A*11:01) | EP11315_1 | 1 mg; 5 mg |
| Influenza A M1 58-66 (HLA-A*02:01) | EP07854_1 | 1 mg; 5 mg |
| Influenza A M1 59-68 (HLA-A*02:01) | EP11322_1 | 1 mg; 5 mg |
| Influenza A M1 Peptide Pool | LB01774 | 15 nmol/peptide |
| Influenza A MP2 70-78 (HLA-A*11:01) | EP11316_1 | 1 mg; 5 mg |
| Influenza A NP 366-374 (H-2 Db) | EP07742_1 | 1 mg; 5 mg |
| Influenza A NP 383-391 (HLA-B*27:05) | EP11318_1 | 1 mg; 5 mg |
| Influenza A NP 44-52 (HLA-A*01:01) | EP11323_1 | 1 mg; 5 mg |
| Influenza A NP 473-481 (HLA-B*07:02) | EP11317_1 | 1 mg; 5 mg |
| Influenza A PB1 329-337 (HLA-B*07:02) | EP11320_1 | 1 mg; 5 mg |
| Influenza A PB1 591-599 (HLA-A*01:01) | EP11319_1 | 1 mg; 5 mg |
| Influenza A virus (A/Puerto Rico/8/1934 (H1N1)) 36-43 (H-2-Kd) | EP12105_1 | 1 mg; 5 mg |
| Influenza A virus (A/Puerto Rico/8/1934(H1N1)) 462-470 (H-2-Kd) | EP12103_1 | 1 mg; 5 mg |
| Influenza A virus 332-340 (H-2-Db) | EP12102_1 | 1 mg; 5 mg |
| Influenza A virus 533-541 (H-2-Kd) | EP12104_1 | 1 mg; 5 mg |
| Influenza A virus HA 306-318 (DRB1*01:01) | EP07851_1 | 1 mg; 5 mg |
| Influenza B BNP 85-94 (HLA-A*02:01) | EP11321_1 | 1 mg; 5 mg |
| Influenza control Peptide Pool (>95% HPLC) | LB01715 | 15 nmol/peptide |
| Influenza NP 147-155 (H-2Kd) | EP12108_1 | 1 mg; 5 mg |
| Influenza NP 218-226 (HLA-A*02:01) | EP12106_1 | 1 mg; 5 mg |
| Influenza NP 418-426 (HLA-B*07:02) | EP11478_1 | 1 mg; 5 mg |
| Influenza NP 50-57 | EP11701_1 | 1 mg; 5 mg |
| Influenza NP 55-63 (HLA-A*02:01) | EP12107_1 | 1 mg |
| Influenza Virus NP 342–351 (HLA-A*03:01)( HLA-A*31:01)( HLA-A*33:01) | EP11476_1 | 1 mg |
| Influenza Virus NP 380-388 (HLA-B*8) | EP11479_1 | 1 mg |
| Influenza Virus NP 91–99 (HLA-A*68:01) | EP11477_1 | 1 mg; 5 mg |
| Influenza Virus PA 46–54 (HLA-A*02:01) | EP11475_1 | 1 mg; 5 mg |
| Iota Variant B.1.526 SCoV2 (Spike Glycoprotein) Peptide Pool | LB01955 | 15 nmol/peptide |
| JC polyomavirus (Large T antigen) Peptide Pool | LB01666 | 15 nmol/peptide |
| JC polyomavirus (VP1) Peptide Pool | LB01561 | 15 nmol/peptide |
| JCV-VP1 100-108 (HLA-A*02:01) | EP11454_1 | 1 mg; 5 mg |
| K8.1 135–143 (HLA-A*02:01) | EP11328_1 | 1 mg; 5 mg |
| Kappa Variant B.1.617.1 SCoV2 (Spike Glycoprotein) Peptide Pool | LB01956 | 15 nmol/peptide |
| Lambda Variant C.37 SCoV2 (Spike Glycoprotein) Peptide Pool | LB01957 | 15 nmol/peptide |
| LANA 1116-1124 (HLA-A*02:01) | EP11333_1 | 1 mg; 5 mg |
| LANA 281-289 (HLA-A*02:01) | EP11332_1 | 1 mg; 5 mg |
| LCMV envelope gp 10-18 (HLA-A*02:01) | EP11238_1 | 1 mg; 5 mg |
| LCMV GP 118-125 | EP14045_1 | 1 mg; 5 mg |
| LCMV gp 276-286 (H-2 Db) | EP07917_1 | 1 mg; 5 mg |
| LCMV GP 33-41 (H-2 Db) | EP07864_1 | 1 mg; 5 mg |
| LCMV GP 64-80 | EP09842_1 | 1 mg; 5 mg |
| LCMV GP33 33-41 (H2-D(b)) | EP11847_1 | 1 mg; 5 mg |
| LCMV GPC 447-455 (HLA-A*02:01) | EP11241_1 | 1 mg |
| LCMV NP (strain Armstrong) Peptide Pool | LB02366 | 15 nmol/peptide |
| LCMV NP 201-215 | EP14043_1 | 1 mg; 5 mg |
| LCMV NP 205-212 | EP14044_1 | 1 mg; 5 mg |
| LCMV NP 309-328 | EP14042_1 | 1 mg; 5 mg |
| LL - 37 | EP11651_1 | 1 mg; 5 mg |
| LL - 37, scrambled | EP11652_1 | 1 mg; 5 mg |
| LLO 189-200 (H2-Kd ) | EP14996_1 | 1 mg; 5 mg |
| LLO 216–227 (H2-Kd) | EP14997_1 | 1 mg; 5 mg |
| LLO 91-99 (H-2 Kd) | EP07863_1 | 1 mg; 5 mg |
| M. tuberculosis esxA esaT6 Peptide Pool | LB02113 | 15 nmol/peptide |
| M. tuberculosis Ag85B Peptide Pool | LB02088 | 15 nmol/peptide |
| M. tuberculosis Alpha-crystallin Peptide Pool | LB02087 | 15 nmol/peptide |
| M. tuberculosis esxB CFP-10 Peptide Pool | LB02112 | 15 nmol/peptide |
| M. tuberculosis esxH (TB10.4) Peptide Pool | LB02078 | 15 nmol/peptide |
| M. tuberculosis hbhA Peptide Pool | LB02357 | 15 nmol/peptide |
| M. tuberculosis hspX Peptide Pool | LB02077 | 15 nmol/peptide |
| M. tuberculosis MPT64 Peptide Pool | LB02367 | 15 nmol/peptide |
| M. tuberculosis PPE68 Peptide Pool | LB02368 | 15 nmol/peptide |
| Mannoprotein MP65 Peptide Pool | LB01937 | 15 nmol/peptide |
| MCMV IE1 | EP11702_1 | 1 mg; 5 mg |
| MCMV m139 419-426 (H2-K(b)) | EP11846_1 | 1 mg; 5 mg |
| MCMV m142 24-38 (H1-A(b)) | EP11848_1 | 1 mg; 5 mg |
| MCMV m38 316-323 (H2-K(b)) | EP11845_1 | 1 mg; 5 mg |
| MCMV M45 985-993 (H-2Db) | EP11844_1 | 1 mg; 5 mg |
| MuLV p15E (H-2Kb ) | EP11849_1 | 1 mg; 5 mg |
| Mycobacterium bovis antigen 85-A 200-208 (HLA-A*02:01) | EP11366_1 | 1 mg; 5 mg |
| Mycobacterium bovis antigen 85-A 6-14 (HLA-A*02:01) | EP11365_1 | 1 mg; 5 mg |
| Myeloperoxidase (MPO) human Peptide Pool | LB02483 | 15 nmol/peptide |
| NCAP-MEASF Peptide Pool | LB02342 | 15 nmol/peptide |
| NS2A 4–13 (HLA-C*03:04) | EP07991_1 | 1 mg; 5 mg |
| NS2b 78-87 (HLA-A*02:01) | EP11466_1 | 1 mg; 5 mg |
| NS3 1581-1589 (HLA A*02:01) | EP11906_1 | 1 mg |
| NS3 518–526 (HLA-A*02:01) | EP11467_1 | 1 mg; 5 mg |
| NS3 73-81 (HLA-B*15:01) | EP12429_1 | 1 mg; 5 mg |
| NS4b 77-91 | EP12427_1 | 1 mg; 5 mg |
| NS5 465-479 | EP12428_1 | 1 mg; 5 mg |
| NS5 862–870 (HLA-A*02:01) | EP11464_1 | 1 mg; 5 mg |
| NS5B 2841-2849 (HLA-B*27:05) | EP11227_1 | 1 mg; 5 mg |
| NS5B 2936-2944 (HLA-B*27:05) | EP09340_1 | 1 mg; 5 mg |
| Nucleocapsid 327-335 (HLA-A*02:01) | EP11372_1 | 1 mg; 5 mg |
| Omicron full length B.1.1.529 SCoV2 (Spike Glycoprotein) Peptide Pool | LB02000 | 15 nmol/peptide |
| Omicron Variant B.1.1.529 SCoV2 (Spike Glycoprotein) Peptide Pool | LB01999 | 15 nmol/peptide |
| Omicron Variant B.1.1.529 SCoV2 wt (Spike Glycoprotein) Peptide Pool | LB02004 | 15 nmol/peptide |
| Op4p Peptide Pool | LB01982 | 15 nmol/peptide |
| ORF2 1-11 | EP11104_1 | 1 mg; 5 mg |
| ORF2 46-54 | EP11105_1 | 1 mg; 5 mg |
| OVA (257-264) mutant 260T (H-2Kb) | EP01706_1 | 1 mg; 5 mg |
| OVA - Y3, SIYNFEKL (H-2Kb) | EP01705_1 | 1 mg; 5 mg |
| OVA (257-264) (H-2Kb) | EP01994_1 | 1 mg; 5 mg |
| OVA 257-268 (H-2 Kb) | EP08950_1 | 1 mg; 5 mg |
| OVA-Peptid (323-339) | EP04609_1 | 1 mg; 5 mg |
| OVA-Peptid (323-339) (H-2Kb) HCl | EP18445_1 | 1 mg; 5 mg |
| OVA-Q4H7 (H-2 Kb) | EP07877_1 | 1 mg; 5 mg |
| PADRE | EP07104_1 | 1 mg; 5 mg |
| PAX-5 311-319 (HLA-A*02:01) | EP11392_1 | 1 mg; 5 mg |
| pH-regulated antigen PRA1 Peptide Pool | LB01980 | 15 nmol/peptide |
| pH-responsive protein 1 Peptide Pool | LB01981 | 15 nmol/peptide |
| Phosphoglycerate kinase Peptide Pool | LB01932 | 15 nmol/peptide |
| Phosphoglycerate mutase Peptide Pool | LB01931 | 15 nmol/peptide |
| Plasmodium falciparum CSP 334-342 (HLA-A*02:01) | EP11394_1 | 1 mg; 5 mg |
| Pol 455-463 (HLA-A*02:01) | EP11395_1 | 1 mg; 5 mg |
| Pol 502-510 (HLA-A*02:01) | EP11396_1 | 1 mg; 5 mg |
| Pr1 169-177 (HLA-A*02:01) | EP06994_1 | 1 mg; 5 mg |
| PTLV-1 bZIP factor 10-18 (HLA-B*07:02) | EP11411_1 | 1 mg; 5 mg |
| PTLV-1 bZIP factor 22-30 (HLA-A*02:01) | EP11409_1 | 1 mg; 5 mg |
| PTLV-1 bZIP factor 26-34 (HLA-A*02:01) | EP11410_1 | 1 mg; 5 mg |
| PTLV-1 bZIP factor 42-50 (HLA-A*02:01) | EP11408_1 | 1 mg; 5 mg |
| Rabies virus (Glycoprotein) Peptide Pool | LB02160 | 15 nmol/peptide |
| RBD B.1.617.2 (Delta) SCoV2 (Spike Glycoprotein) Peptide Pool | LB02082 | 15 nmol/peptide |
| RSV control Peptide Pool (>95% HPLC) | LB01720 | 15 nmol/peptide |
| RSV Fusion glycoprotein F0 precursor 106-114 (HLA-B57) | EP12233_1 | 1 mg; 5 mg |
| RSV Fusion glycoprotein F0 precursor 542-550 (HLA-Cw12) | EP12235_1 | 1 mg; 5 mg |
| RSV Fusion protein 10-18 (HLA-A*02:01) | EP12211_1 | 1 mg; 5 mg |
| RSV Fusion protein 114-122 (HLA-A*02:01) | EP12215_1 | 1 mg |
| RSV Fusion protein 140-148 (HLA-A*02:01) | EP12214_1 | 1 mg; 5 mg |
| RSV Fusion protein 159-167 (HLA-A*02:01) | EP12216_1 | 1 mg; 5 mg |
| RSV Fusion protein 170-178 (HLA-A*02:01) | EP12212_1 | 1 mg; 5 mg |
| RSV Fusion protein 171-179 (HLA-A*02:01) | EP12222_1 | 1 mg; 5 mg |
| RSV Fusion protein 173-181 (HLA-A*02:01) | EP12227_1 | 1 mg; 5 mg |
| RSV Fusion protein 180-188 (HLA-A*02:01) | EP12226_1 | 1 mg; 5 mg |
| RSV Fusion protein 191-199 (HLA-A*02:01) | EP12220_1 | 1 mg; 5 mg |
| RSV Fusion protein 250-258 (HLA-A*02:01) | EP12229_1 | 1 mg; 5 mg |
| RSV Fusion protein 272-280 (HLA-A*02:01) | EP12219_1 | 1 mg; 5 mg |
| RSV Fusion protein 273-281 (HLA-A*02:01) | EP12223_1 | 1 mg; 5 mg |
| RSV Fusion protein 394-402 (HLA-A*02:01) | EP12217_1 | 1 mg; 5 mg |
| RSV Fusion protein 451-459 (HLA-A*02:01) | EP12228_1 | 1 mg; 5 mg |
| RSV Fusion protein 498-506 (HLA-A*02:01) | EP12218_1 | 1 mg; 5 mg |
| RSV Fusion protein 538-546 (HLA-A*02:01) | EP12221_1 | 1 mg; 5 mg |
| RSV Fusion protein 540-548 (HLA-A*02:01) | EP12225_1 | 1 mg; 5 mg |
| RSV Fusion protein 82-90 (HLA-A*02:01) | EP12213_1 | 1 mg; 5 mg |
| RSV MP 229-237 (HLA-A*01:01) | EP12210_1 | 1 mg; 5 mg |
| RSV MP2 151-159 (HLA-A*03:01) | EP12230_1 | 1 mg; 5 mg |
| RSV MP2 64-72 (HLA-B44) | EP12234_1 | 1 mg; 5 mg |
| RSV NP 137-145 (HLA-A*02:01) | EP10768_1 | 1 mg; 5 mg |
| RSV NP 16-24 (HLA-A*02:01) | EP12224_1 | 1 mg; 5 mg |
| RSV NP 255-263 (HLA-B*08:01) | EP12232_1 | 1 mg; 5 mg |
| RSV NP 306-314 (HLA-B*07:02) | EP12231_1 | 1 mg; 5 mg |
| RSVA Peptide Pool | LB01691 | 15 nmol/peptide |
| SAAP-148 | EP20154_1 | 1 mg; 5 mg |
| SARS-CoV Nucleocapsid A2 (HLA-A*02:01) | EP14603_1 | 1 mg; 5 mg |
| SARS-CoV Nucleocapsid A2 (HLA-A*02:01) | EP14604_1 | 1 mg; 5 mg |
| SARS-CoV Nucleocapsid A2 138-146 (HLA-A*02:01) | EP14599_1 | 1 mg; 5 mg |
| SARS-CoV Nucleocapsid A2 219-227 (HLA-A*02:01) | EP14600_1 | 1 mg; 5 mg |
| SARS-CoV Nucleocapsid A2 226-234 (HLA-A*02:01) | EP14601_1 | 1 mg; 5 mg |
| SARS-CoV SSp-1 A2 (HLA-A*02:01) | EP14587_1 | 1 mg; 5 mg |
| SARS-CoV-2 (M-Protein) Peptide Pool | LB01794 | 15 nmol/peptide |
| SARS-CoV-2 (N-Protein) Peptide Pool | LB02293 | 15 nmol/peptide |
| SARS-CoV-2 (NS6) Peptide Pool | LB01787 | 15 nmol/peptide |
| SARS-CoV-2 (NS7a) Peptide Pool | LB01797 | 15 nmol/peptide |
| SARS-CoV-2 (NS7b) Peptide Pool | LB01788 | 15 nmol/peptide |
| SARS-CoV-2 (NS8) Peptide Pool | LB01789 | 15 nmol/peptide |
| SARS-CoV-2 (ORF10) Peptide Pool | LB01790 | 15 nmol/peptide |
| SARS-CoV-2 (ORF3a) Peptide Pool | LB01785 | 15 nmol/peptide |
| SARS-CoV-2 (ORF9b) Peptide Pool | LB01791 | 15 nmol/peptide |
| SARS-CoV-2 (ORF9c) Peptide Pool | LB01795 | 15 nmol/peptide |
| SARS-CoV-2 (Spike Glycoprotein) Peptide Pool | LB02294 | 15 nmol/peptide |
| SARS-CoV-2 (VEMP) Peptide Pool | LB01793 | 15 nmol/peptide |
| SARS-CoV-2 Membrane GP A2 61-70 (HLA-A*02:01) | EP14597_1 | 1 mg; 5 mg |
| SARS-CoV-2 Membrane GP A2 89-97 (HLA-A*02:01) | EP14598_1 | 1 mg; 5 mg |
| SARS-CoV-2 Membrane GP_1 A2 (HLA-A*02:01) | EP14608_1 | 1 mg; 5 mg |
| SARS-CoV-2 Membrane GP_2 A2 (HLA-A*02:01) | EP14609_1 | 1 mg; 5 mg |
| SARS-CoV-2 Nucleocapsid A2 N223-231 (HLA-A*02:01) | EP14602_1 | 1 mg; 5 mg |
| SARS-CoV-2 Nucleocapsid_1 B7 (HLA-B*07:02) | EP14614_1 | 1 mg; 5 mg |
| SARS-CoV-2 Nucleocapsid_2 B7 (HLA-B*07:02) | EP14615_1 | 1 mg; 5 mg |
| SARS-CoV-2 Nucleocapsid_3 B7 (HLA-B*07:02) | EP14616_1 | 1 mg; 5 mg |
| SARS-CoV-2 ORF3a prot_1 A2 (HLA-A*02:01) | EP14610_1 | 1 mg; 5 mg |
| SARS-CoV-2 ORF3a prot_2 A2 (HLA-A*02:01) | EP14611_1 | 1 mg; 5 mg |
| SARS-CoV-2 ORF6 prot_1 A2 (HLA-A*02:01) | EP14612_1 | 1 mg; 5 mg |
| SARS-CoV-2 Surface GP A2 1000-1008 (HLA-A*02:01) | EP14814_1 | 1 mg; 5 mg |
| SARS-CoV-2 Surface GP A2 1192–1200 (HLA-A*02:01) | EP14595_1 | 1 mg; 5 mg |
| SARS-CoV-2 Surface GP A2 1220–1228 (HLA-A*02:01) | EP14596_1 | 1 mg; 5 mg |
| SARS-CoV-2 Surface GP A2 424–433 (HLA-A*02:01) | EP14590_1 | 1 mg; 5 mg |
| SARS-CoV-2 Surface GP A2 691–699 (HLA-A*02:01) | EP14591_1 | 1 mg; 5 mg |
| SARS-CoV-2 Surface GP A2 958–966 (HLA-A*02:01) | EP14592_1 | 1 mg; 5 mg |
| SARS-CoV-2 Surface GP A2 978–986 (HLA-A*02:01) | EP14594_1 | 1 mg; 5 mg |
| SARS-CoV-2 Surface GP_1 A2 (HLA-A*02:01) | EP14605_1 | 1 mg; 5 mg |
| SARS-CoV-2 Surface GP_1 B7 (HLA-B*07:02) | EP14617_1 | 1 mg; 5 mg |
| SARS-CoV-2 Surface GP_2 A2 (HLA-A*02:01) | EP14593_1 | 1 mg; 5 mg |
| SARS-CoV-2 Surface GP_3 A2 (HLA-A*02:01) | EP14613_1 | 1 mg; 5 mg |
| Secreted beta-glucosidase SUN41 Peptide Pool | LB01933 | 15 nmol/peptide |
| Secreted protein RBT4 Peptide Pool | LB01936 | 15 nmol/peptide |
| Tetanus Toxin Peptide Pool | LB01288 | 15 nmol/peptide |
| Theta Variant P.3 SCoV2 (Spike Glycoprotein) Peptide Pool | LB01954 | 15 nmol/peptide |
| Tos1p Peptide Pool | LB01935 | 15 nmol/peptide |
| Transaldolase Peptide Pool | LB01929 | 15 nmol/peptide |
| Vaccinia virus Copenhagen Protein G5 18-26 (HLA-A*02:01) | EP11450_1 | 1 mg; 5 mg |
| Vaccinia virus Host range protein 2 74-82 (HLA-A*02:01) | EP11451_1 | 1 mg; 5 mg |
| VP1 36-44 (HLA-A*02:01) | EP11457_1 | 1 mg; 5 mg |
| VP1 372-380 (HLA-B*07:02) | EP11463_1 | 1 mg; 5 mg |
| VP1 437-445 (HLA-A*02:01) | EP11455_1 | 1 mg; 5 mg |
| VP1 44-52 (HLA-A*02:01) | EP11453_1 | 1 mg; 5 mg |
| VP1 80-88 (HLA-B*07:02) | EP11462_1 | 1 mg; 5 mg |
| VZV (gE) Peptide Pool | LB02248 | 15 nmol/peptide |
| VZV (IE63) Peptide Pool | LB01819 | 15 nmol/peptide |
| XBB.1.5.X Omicron full length SCoV2 (Spike Glycoprotein) Peptide Pool | LB02145 | 15 nmol/peptide |
| Zeta Variant P.2 SCoV2 (Spike Glycoprotein) Peptide Pool | LB01952 | 15 nmol/peptide |
| ABI2 145-153 (HLA-A*02:01) | EP11074_1 | 1 mg; 5 mg |
| ABL1 (HLA-A*02:01) | EP11075_1 | 1 mg; 5 mg |
| Adpgk Neoepitope (H-2D(b)) | EP11850_1 | 1 mg; 5 mg |
| Anti-H60a 39-46 (H-2Kb) | EP11648_1 | 1 mg; 5 mg |
| BA46 194-202 (HLA-A*02:01) | EP11078_1 | 1 mg; 5 mg |
| BA46 97-106 (HLA-A*02:01) | EP11077_1 | 1 mg; 5 mg |
| BAP31 167-175 (HLA-A*02:01) | EP11079_1 | 1 mg; 5 mg |
| BCL-2 180-189 (HLA-A*02:01) | EP11083_1 | 1 mg; 5 mg |
| BCL-2 208-217 (HLA-A*02:01) | EP11081_1 | 1 mg; 5 mg |
| Bcl-2 214-223 (HLA-A*02:01) | EP07886_1 | 1 mg; 5 mg |
| BCL-2 85-93 (HLA-A*02:01) | EP11080_1 | 1 mg; 5 mg |
| BCL-2A1 15-23 (HLA-A*24:02) | EP11084_1 | 1 mg; 5 mg |
| BCL-2L1 165-173 (HLA-A*03:01) | EP11085_1 | 1 mg; 5 mg |
| BCL2-like 1 173-182 (HLA-A*02:01) | EP11086_1 | 1 mg; 5 mg |
| BCR-ABL (HLA-A*02:01) | EP11087_1 | 1 mg; 5 mg |
| BCR-ABL 19-27 (HLA-B*27:01) | EP11090_1 | 1 mg; 5 mg |
| BCR-ABL 926-934 (HLA-A*02:01) | EP12190_1 | 1 mg; 5 mg |
| BCR/ABL 210 kD fusion protein 21-29 (HLA-A*03:01) | EP11089_1 | 1 mg; 5 mg |
| BCR/ABL 210 kD fusion protein 259-269 (HLA-A*03:01) (HLA-A*11:01) | EP11088_1 | 1 mg; 5 mg |
| BGLAP (HLA-A*24:02) | EP11092_1 | 1 mg; 5 mg |
| BGLAP 1-10 (HLA-A*02:01) | EP11091_1 | 1 mg; 5 mg |
| BMI1 (271-279) (HLA-A*02:01) | EP11099_1 | 1 mg; 5 mg |
| BMI1 (74-82) (HLA-A*02:01) | EP11100_1 | 1 mg; 5 mg |
| BRAF 594-601 mutant (HLA-B*27:05) 600E | EP11101_1 | 1 mg; 5 mg |
| BRAF 594-601 mutant (HLA-B*27:05) 600V | EP11102_1 | 1 mg; 5 mg |
| BRLF1 109-117 (HLA-A*02:01) | EP11139_1 | 1 mg; 5 mg |
| Carbonic anhydrase 219-227 (HLA-A*24:02) | EP11106_1 | 1 mg; 5 mg |
| CB9L2 (HLA-A*02:01) | EP11107_1 | 1 mg; 5 mg |
| CD20 188-196 (HLA-A*02:01) | EP07888_1 | 1 mg; 5 mg |
| CD22 antigen (HLA-A*02:01) | EP07885_1 | 1 mg; 5 mg |
| CD22 antigen 459-467 (HLA-A*02:01) | EP07884_1 | 1 mg; 5 mg |
| CD22-4 371-379 (HLA-A*02:01) | EP07909_1 | 1 mg; 5 mg |
| CD33 65-73 mutant (HLA-A*02:01) 65Y, 66L | EP11108_1 | 1 mg; 5 mg |
| CD59 glycoprotein precursor 106-114 (HLA-A*02:01) | EP11109_1 | 1 mg; 5 mg |
| CD79b 52-60 (HLA-A*02:01) | EP07910_1 | 1 mg; 5 mg |
| CEA 605-613 (HLA-A*02:01) | EP07878_1 | 1 mg; 5 mg |
| CEA 605-613 mutant (HLA-A*02:01) 610D | EP11112_1 | 1 mg; 5 mg |
| CEA 652-660 (HLA-A*24:02) | EP11111_1 | 1 mg; 5 mg |
| CEA 694-702 (HLA-A*02:01) | EP11110_1 | 1 mg; 5 mg |
| CEACAM 185-193 (HLA-B*07:02) | EP11113_1 | 1 mg; 5 mg |
| Chondromodulin-I 319-327 (HLA-A*02:01) | EP11115_1 | 1 mg; 5 mg |
| Cyclin A1 227-235 (HLA-A*02:01) | EP07912_1 | 1 mg; 5 mg |
| Cytochrome p450 1B1 239-248 (HLA-A*02:01) | EP11124_1 | 1 mg; 5 mg |
| DEP DC1 294-302 (HLA-A*24:02) | EP11125_1 | 1 mg; 5 mg |
| DLK1 309-317 (HLA-A*02:01) | EP11126_1 | 1 mg; 5 mg |
| EBNA 3a (596-604) | EP10789_1 | 1 mg; 5 mg |
| EBV (BZLF1) Peptide Pool | LB01667 | 15 nmol/peptide |
| EBV (EBNA-3b) Peptide Pool | LB01688 | 15 nmol/peptide |
| EBV (GP350/GP340) Peptide Pool | LB01855 | 15 nmol/peptide |
| EBV (LMP1) Peptide Pool | LB01689 | 15 nmol/peptide |
| EBV (LMP2) Peptide Pool | LB01690 | 15 nmol/peptide |
| EBV (LMP2A) Peptide Pool | LB01696 | 15 nmol/peptide |
| EBV BALF-4 276-284 (HLA-A*02:01) | EP11237_1 | 1 mg; 5 mg |
| EBV BARF1 Peptide Pool | LB02234 | 15 nmol/peptide |
| EBV BMRF1 116-128 (HLA-B*07:02) | EP11138_1 | 1 mg; 5 mg |
| EBV BMRF1 208-216 (HLA-A*02:01) | EP11127_1 | 1 mg; 5 mg |
| EBV BPLF1 1395-1407 (DRA1*01:01/DRB1*03:01) | EP20307_1 | 1 mg; 5 mg |
| EBV BRLF-1 148-156 (HLA-A*03:01) | EP11482_1 | 1 mg; 5 mg |
| EBV BRLF1 101-109 (HLA-A*29:02) | EP11142_1 | 1 mg; 5 mg |
| EBV BRLF1 134-142 (HLA-A*11:01) | EP11140_1 | 1 mg; 5 mg |
| EBV BRLF1 28-37 (HLA-A*24:02) | EP11141_1 | 1 mg; 5 mg |
| EBV BZLF-1 54-64 (HLA-B*35:01) | EP11143_1 | 1 mg; 5 mg |
| EBV BZLF-1 54-64 mutant (HLA-B*35:01) | EP11144_1 | 1 mg; 5 mg |
| EBV BZLF1 44-52 (HLA-B*07:02) | EP11214_1 | 1 mg; 5 mg |
| EBV control Peptide Pool (>95% HPLC) | LB01714 | 15 nmol/peptide |
| EBV EBNA 3A 246-253 (HLA-A*24:02) | EP11147_1 | 1 mg; 5 mg |
| EBV EBNA 3B 399-408 (HLA-A*11:01) | EP11150_1 | 1 mg; 5 mg |
| EBV EBNA 3C 258-266 (HLA-B*27:02)(HLA-B*27:05)(HLA-B*27:04) | EP11481_1 | 1 mg; 5 mg |
| EBV EBNA-1 407-417 (HLA-B*35:01) | EP08274_1 | 1 mg; 5 mg |
| EBV EBNA-1 407-417 mutant (HLA-B*35:01) 410A | EP11145_1 | 1 mg; 5 mg |
| EBV EBNA-1 407-417 mutant (HLA-B*35:08) 411D | EP11146_1 | 1 mg; 5 mg |
| EBV EBNA-1 72-80 (HLA-B*35:01) | EP14015_1 | 1 mg; 5 mg |
| EBV EBNA-1 Peptide Pool | LB01674 | 15 nmol/peptide |
| EBV EBNA-2 Peptide Pool | LB02350 | 15 nmol/peptide |
| EBV EBNA-3A 325-333 (HLA-B*08:01) | EP06163_1 | 1 mg; 5 mg |
| EBV EBNA-3A 458-466 (HLA-B*35:01) | EP11148_1 | 1 mg; 5 mg |
| EBV EBNA-3C 284-293 (HLA-A*02:01) | EP11149_1 | 1 mg; 5 mg |
| EBV EBNA-3C 881-889 (HLA-B*07:02) | EP11152_1 | 1 mg; 5 mg |
| EBV EBNA2 280-290 (DRB1*01:01) | EP20308_1 | 1 mg; 5 mg |
| EBV EBNA3A 158-166 (HLA-B*08:01) | EP11153_1 | 1 mg; 5 mg |
| EBV EBNA3B 416-424 (HLA-A*11:01; HLA-A*68:01) | EP11151_1 | 1 mg; 5 mg |
| EBV EBNA3C 281-290 (HLA-B*44:05) | EP11483_1 | 1 mg; 5 mg |
| EBV GP340 768-782 | EP20306_1 | 1 mg; 5 mg |
| EBV LMP-1 125-133 (HLA-A*02:01) | EP11154_1 | 1 mg |
| EBV LMP-2 340-349 (HLA-A*11:01) | EP11156_1 | 1 mg; 5 mg |
| EBV LMP-2 340-349 mutant (HLA-A*11:01) 348T | EP14582_1 | 1 mg; 5 mg |
| EBV LMP-2 419-427 (HLA-A*24:02) | EP11157_1 | 1 mg; 5 mg |
| EBV LMP-2 426-434 (HLA-A*02:01) | EP08605_1 | 1 mg |
| EBV LMP1 159-167 (HLA-A*02:01) | EP11155_1 | 1 mg |
| EBV LMP2 200-208 (HLA-B*40:01) | EP11159_1 | 1 mg; 5 mg |
| EBV LMP2 419-427 mutant 426S (HLA-A*24:02) | EP11158_1 | 1 mg; 5 mg |
| EDDR1 867-876 (HLA-A*02:01) | EP11160_1 | 1 mg; 5 mg |
| EGF-R 1138-1147 (HLA-A*02:01) | EP11161_1 | 1 mg |
| EGF-R-479 350-359 (HLA-A*02:01) | EP11162_1 | 1 mg; 5 mg |
| Endosialin 691-700 (HLA-A*02:01) | EP11163_1 | 1 mg; 5 mg |
| EphA2 883-891 (HLA-A*02:01) | EP11164_1 | 1 mg; 5 mg |
| EZH2 666-674 (HLA-A*02:01) | EP11167_1 | 1 mg; 5 mg |
| EZH2 729-737 (HLA-A*02:01) | EP11166_1 | 1 mg; 5 mg |
| FAP 735-744 (HLA-A*02:01) | EP07907_1 | 1 mg; 5 mg |
| FAP alpha 463-471 (HLA-A*02:01) | EP11168_1 | 1 mg; 5 mg |
| FAP alpha 639-647 (HLA-A*02:01) | EP11169_1 | 1 mg; 5 mg |
| Fibromodulin F1 7-17 (HLA-A*02:01) | EP07903_1 | 1 mg; 5 mg |
| Fibromodulin F2 206-215 (HLA-A*02:01) | EP07904_1 | 1 mg; 5 mg |
| Fibromodulin F3 250-259 (HLA-A*02:01) | EP07905_1 | 1 mg; 5 mg |
| Fibromodulin F4 226-235 (HLA-A*02:01) | EP07906_1 | 1 mg; 5 mg |
| FKBP6_HUMAN Peptide Pool | LB02222 | 15 nmol/peptide |
| FLT1 (HLA-A*02:01) | EP11170_1 | 1 mg; 5 mg |
| FOLR1 191-199 (HLA-A*02:01) | EP11171_1 | 1 mg; 5 mg |
| FOXM1 262-270 (HLA-A*24:02) | EP11172_1 | 1 mg; 5 mg |
| G250 217-225 (HLA-A*02:01) | EP11175_1 | 1 mg; 5 mg |
| Glyceraldehyde-3-phosphate dehydrogenase Peptide Pool | LB01930 | 15 nmol/peptide |
| gp100 (pmel17) 476-485 (HLA-A*02:01) | EP11184_1 | 1 mg; 5 mg |
| gp100 154-162 (HLA-A*02:01) | EP11180_1 | 1 mg; 5 mg |
| gp100 17-25 (HLA-A*03:01) | EP11182_1 | 1 mg; 5 mg |
| gp100 170-178 (HLA-A*24:02) | EP11183_1 | 1 mg; 5 mg |
| gp100 209-217 (HLA-A*02:01) | EP07861_1 | 1 mg; 5 mg |
| gp100 209-217 mutant (HLA-A*02:01) 210M | EP07860_1 | 1 mg; 5 mg |
| gp100 280-288 (HLA-A*02:01) | EP07871_1 | 1 mg; 5 mg |
| gp100 280-288 mutant (HLA-A*02:01) 288V | EP11181_1 | 1 mg; 5 mg |
| GPC3 144-152 (HLA-A*02:01) | EP11178_1 | 1 mg; 5 mg |
| GPC3 298-306 (HLA-A*24:02) | EP11179_1 | 1 mg; 5 mg |
| HA-1 137-145 His139 (HLA-A*02:01) | EP07865_1 | 1 mg; 5 mg |
| HBV control Peptide Pool (>95% HPLC) | LB01716 | 15 nmol/peptide |
| HBV core 117-125 (HLA-A*24:02) | EP11187_1 | 1 mg; 5 mg |
| HBV core 18-27 (subtype ADR4) (HLA-A*02:01) | EP11189_1 | 1 mg; 5 mg |
| HBV core 19-27 (HLA-B*35:01) (HLA-B*51:01) | EP11191_1 | 1 mg; 5 mg |
| HBV core antigen 88-96 (HLA-A*11:01) | EP11190_1 | 1 mg; 5 mg |
| HBV envelope 183-191 (HLA-A*02:01) | EP11194_1 | 1 mg; 5 mg |
| HBV envelope 335-343 (HLA-A*02:01) | EP11196_1 | 1 mg; 5 mg |
| HBV envelope 348-357 (HLA-A*02:01) | EP11195_1 | 1 mg; 5 mg |
| HBV HBsAg 190-197 (H-2 Kb) | EP11485_1 | 1 mg; 5 mg |
| HBV HBsAg 371-378 (H2-Kb) | EP11486_1 | 1 mg |
| HBV polymerase 575 - 583 (HLA-A*02:01) | EP11192_1 | 1 mg; 5 mg |
| HBV polymerase 756-764 (HLA-A*24:02) | EP11193_1 | 1 mg; 5 mg |
| HBV Protein P Peptide Pool | LB01730 | 15 nmol/peptide |
| Hepatocyte cell adhesion molecule (human) Peptide Pool | LB02154 | 15 nmol/peptide |
| HER-2 434-443 (HLA-A*02:01) | EP11234_1 | 1 mg; 5 mg |
| HER-2/neu 369-377 (HLA-A*02:01) | EP07858_1 | 1 mg; 5 mg |
| HER-2/neu 435-443 (HLA-A*02:01) | EP11232_1 | 1 mg; 5 mg |
| HER-2/neu 63-71 (HLA-A*24:02) | EP11233_1 | 1 mg; 5 mg |
| HER-2/neu 689-697 (HLA-A*02:01) | EP07859_1 | 1 mg; 5 mg |
| HER-2/neu 85–94 (HLA-A*02:01) | EP11235_1 | 1 mg; 5 mg |
| HERV-K Gag 139-147 (HLA-A*02:01) | EP07897_1 | 1 mg; 5 mg |
| HERV-K Gag 155-163 (HLA-A*02:01) | EP07898_1 | 1 mg; 5 mg |
| HJURP (HLA-A*24:02) | EP11283_1 | 1 mg; 5 mg |
| HM1.24 126-134 (HLA-A*02:01) | EP07867_1 | 1 mg; 5 mg |
| hMena 502-510 (HLA-A*02:01) | EP11285_1 | 1 mg; 5 mg |
| HMOX1 265-272 (HLA-B*08:01) | EP11287_1 | 1 mg; 5 mg |
| HNRNPA1 339-348 (HLA C*07:02) | EP13050_1 | 1 mg; 5 mg |
| HO-1 212-220 (HLA-A*02:01) | EP11288_1 | 1 mg; 5 mg |
| HSP105 128-136 (HLA-A*02:01) | EP11296_1 | 1 mg; 5 mg |
| HSP105 180-188 (HLA-A*24:02) | EP11298_1 | 1 mg; 5 mg |
| HSP105 234-243 (HLA-A*02:01) | EP11295_1 | 1 mg; 5 mg |
| HSP105 640–649 (HLA-A*24:02) | EP11297_1 | 1 mg; 5 mg |
| HsPSMA 634-642 (H-2 Db) | EP07902_1 | 1 mg; 5 mg |
| hTERT 653-661 (HLA-A*02:01) | EP11433_1 | 1 mg; 5 mg |
| hTERT 663-672 (HLA-A*03:01) | EP11299_1 | 1 mg; 5 mg |
| hTOM34p (HLA-A*24:02) | EP11302_1 | 1 mg; 5 mg |
| hTRT 461-469 (HLA-A*24:02) | EP11303_1 | 1 mg; 5 mg |
| hTRT 540-548 (HLA-A*02:01) | EP11432_1 | 1 mg; 5 mg |
| hTRT 615-624 (HLA-A*02:01) | EP11430_1 | 1 mg; 5 mg |
| hTRT 674-683 (HLA-A*02:01) | EP11431_1 | 1 mg; 5 mg |
| hTRT 865-873 (HLA-A*02:01) | EP11435_1 | 1 mg; 5 mg |
| hTRT 988-997 (HLA-A*02:01) | EP11434_1 | 1 mg; 5 mg |
| HUMAN (SOX2) Peptide Pool | LB01348 | 15 nmol/peptide |
| HUMAN AFP Peptide Pool | LB01654 | 15 nmol/peptide |
| HUMAN CEP55 Peptide Pool | LB01751 | 15 nmol/peptide |
| HUMAN CT45A1 Peptide Pool | LB01672 | 15 nmol/peptide |
| HUMAN CT83 Peptide Pool (KKLC1) | LB01673 | 15 nmol/peptide |
| HUMAN ENO1 Peptide Pool | LB01461 | 15 nmol/peptide |
| HUMAN gp100 Peptide Pool | LB01350 | 15 nmol/peptide |
| HUMAN HA-1 Peptide Pool | LB02513 | 15 nmol/peptide |
| HUMAN KRT18 Peptide Pool | LB02381 | 15 nmol/peptide |
| HUMAN LAGE1 (CTAG2) Peptide Pool | LB01670 | 15 nmol/peptide |
| HUMAN MAGEA1 Peptide Pool | LB01402 | 15 nmol/peptide |
| HUMAN MAGEA10 Peptide Pool | LB02512 | 15 nmol/peptide |
| HUMAN MAGEA3 Peptide Pool | LB02268 | 15 nmol/peptide |
| HUMAN MAGEA4 Peptide Pool | LB01692 | 15 nmol/peptide |
| HUMAN MAGEA6 Peptide Pool | LB01749 | 15 nmol/peptide |
| HUMAN MAGEC1 Peptide Pool | LB01693 | 15 nmol/peptide |
| HUMAN MAGED1 Peptide Pool | LB01668 | 15 nmol/peptide |
| HUMAN Melan-A/MART-1 Peptide Pool | LB01404 | 15 nmol/peptide |
| HUMAN MUC1 Peptide Pool | LB02522 | 15 nmol/peptide |
| HUMAN NY-ESO-1 Peptide Pool | LB01362 | 15 nmol/peptide |
| HUMAN PBK Peptide Pool | LB01750 | 15 nmol/peptide |
| Human PRAME 254-262 (HLA-A24) | EP14927_1 | 1 mg; 5 mg |
| HUMAN PRAME/OIP4 Peptide Pool | LB01686 | 15 nmol/peptide |
| HUMAN SSX4 Peptide Pool | LB02520 | 15 nmol/peptide |
| HUMAN Survivin Peptide Pool | LB01349 | 15 nmol/peptide |
| HUMAN SYCP1 Peptide Pool | LB02521 | 15 nmol/peptide |
| HUMAN THBS2 Peptide Pool | LB02383 | 15 nmol/peptide |
| HUMAN TPBG Peptide Pool | LB02380 | 15 nmol/peptide |
| HUMAN TSGA10 Peptide Pool | LB01676 | 15 nmol/peptide |
| HUMAN TTK Peptide Pool | LB01756 | 15 nmol/peptide |
| HUMAN TWIST1 Peptide Pool | LB02382 | 15 nmol/peptide |
| HUMAN Tyrosinase Peptide Pool | LB01351 | 15 nmol/peptide |
| HUMAN Tyrosinase-related protein2 Peptide Pool | LB01352 | 15 nmol/peptide |
| HUMAN WT1 Peptide Pool | LB01471 | 15 nmol/peptide |
| HUMAN XAGE-1 Peptide Pool | LB01669 | 15 nmol/peptide |
| IA-2 797-805 (HLA-A*02:01) | EP11304_1 | 1 mg; 5 mg |
| IA-2 805-813 (HLA-A*02:01) | EP11305_1 | 1 mg; 5 mg |
| IL13r 146-154 (HLA-A*24:02) | EP11311_1 | 1 mg; 5 mg |
| IL13Ra 345-353 (HLA-A*02:01) | EP11312_1 | 1 mg; 5 mg |
| Interleukin-17A human Peptide Pool | LB01966 | 15 nmol/peptide |
| ITGB8 662-670 (HLA-A*02:01) | EP11327_1 | 1 mg; 5 mg |
| KIF20A (HLA-A*24:02) | EP11329_1 | 1 mg; 5 mg |
| KIF20A 67-75 (HLA-A*24:02) | EP11330_1 | 1 mg; 5 mg |
| LY6K (HLA-A*02:01) | EP11339_1 | 1 mg |
| LY6K 177-186 (HLA-A*24:02) | EP11340_1 | 1 mg; 5 mg |
| MAGE - A2 mutant (157-166) 161I | EP10165_1 | 1 mg; 5 mg |
| MAGE 212-220 (HLA-C*07:01) | EP07901_1 | 1 mg |
| MAGE-A1 161-169 (HLA-A*01:01) | EP07875_1 | 1 mg; 5 mg |
| MAGE-A1 278-286 (HLA-A*02:01) | EP11344_1 | 1 mg; 5 mg |
| MAGE-A1 289-298 (HLA-B*07:02) | EP11345_1 | 1 mg; 5 mg |
| MAGE-A1-3/A5 Mouse Kb/Db | EP14040_1 | 1 mg; 5 mg |
| MAGE-A2 156-164 (HLA-A*24:02) | EP11349_1 | 1 mg; 5 mg |
| MAGE-A2 157-166 (HLA-A*02:01) | EP11346_1 | 1 mg; 5 mg |
| MAGE-A3 112-120 (HLA-A*02:01) | EP11347_1 | 1 mg; 5 mg |
| MAGE-A3 112-120 mutant (HLA-A*02:01) | EP11351_1 | 1 mg |
| MAGE-A3 168-176 (HLA-A*01:01) | EP11342_1 | 1 mg; 5 mg |
| MAGE-A3 271-279 (HLA-A*02:01) | EP09831_1 | 1 mg |
| MAGE-A3 97-105 (HLA-A*24:02) | EP11350_1 | 1 mg; 5 mg |
| MAGE-A4 230–239 (HLA-A*02:01) | EP11343_1 | 1 mg; 5 mg |
| MAGE-C1 1087-1095 (HLA-A*02:01) | EP11438_1 | 1 mg |
| MAGE-C2 191-200 (HLA-A*2) | EP12155_1 | 1 mg; 5 mg |
| MAGEA-10 254-262 (HLA-A*02:01) | EP11341_1 | 1 mg; 5 mg |
| MART-1 26-35 (HLA-B*35:01) | EP11352_1 | 1 mg; 5 mg |
| Mcl-1 95-103 (HLA-A*03:01) | EP11353_1 | 1 mg; 5 mg |
| Melan - A, MART 1 (26 - 35) | EP09832_1 | 1 mg; 5 mg |
| Melan - A, MART 1 26-35 mutant (HLA-A*02:01) 27L | EP05754_1 | 1 mg; 5 mg |
| Melan A 27-35 | EP10115_1 | 1 mg; 5 mg |
| MELK 87-95 (HLA-A*24:02) 93N | EP11354_1 | 1 mg; 5 mg |
| Mena protein (overexpressed in breast cancer) (HLA-A*02:01) | EP11355_1 | 1 mg; 5 mg |
| Meso GPI (271-630) Sub Peptide Pool | LB01445 | 15 nmol/peptide |
| Mesothelin (290-625) Peptide Pool | LB01568 | 15 nmol/peptide |
| Mesothelin 20-28 (HLA-A*02:01) | EP11359_1 | 1 mg; 5 mg |
| Mesothelin 429-437 (HLA-A*01:01) | EP11358_1 | 1 mg; 5 mg |
| Mesothelin 530–538 (HLA-A*02:01) | EP11360_1 | 1 mg; 5 mg |
| Mesothelin MSLN_HUMAN Peptide Pool | LB02228 | 15 nmol/peptide |
| MG50 210-218 (HLA-A*02:01) | EP12154_1 | 1 mg; 5 mg |
| Midkine 110-119 (HLA-A*24:02) | EP11357_1 | 1 mg; 5 mg |
| Midkine 114–122 (HLA-A*02:01) | EP11356_1 | 1 mg; 5 mg |
| miHAg H-Y (human SMCY) 311-319 (HLA-A*02:01) | EP11185_1 | 1 mg; 5 mg |
| miHAg HA-8 (HLA-A*02:01) | EP11188_1 | 1 mg; 5 mg |
| MOUSE Survivin Peptide Pool | LB01731 | 15 nmol/peptide |
| mTERT 572-580 (HLA-A*02:01) | EP11361_1 | 1 mg; 5 mg |
| MUC1 (HLA-B*07:02) | EP07869_1 | 1 mg; 5 mg |
| MUC1 950-958 (HLA-A*02:01) | EP07868_1 | 1 mg; 5 mg |
| NRP-1 433–441 (HLA-A*02:01) | EP11370_1 | 1 mg; 5 mg |
| NRP-A7 (H-2Kd) | EP12930_1 | 1 mg; 5 mg |
| NRP-V7 (H-2Kd) | EP12929_1 | 1 mg; 5 mg |
| NY-ESO-1 108–116 (HLA-A*02:01) | EP11496_1 | 1 mg; 5 mg |
| NY-ESO-1 127-136 (HLA-A*68:01) | EP11375_1 | 1 mg; 5 mg |
| NY-ESO-1 153-170 (HLA-B*15:17) | EP11839_1 | 1 mg; 5 mg |
| NY-ESO-1 157-165 (HLA-A*02:01) | EP07862_1 | 1 mg; 5 mg |
| NY-ESO-1 157-165 mutant (HLA-A*02:01) 165C | EP11374_1 | 1 mg; 5 mg |
| NY-ESO-1 158-166 (HLA-A*24:02) | EP11838_1 | 1 mg; 5 mg |
| NY-ESO-1 86-94 (HLA-A*02:01) | EP11498_1 | 1 mg; 5 mg |
| NY-ESO-1 93-101 (HLA-B*07:02) | EP11497_1 | 1 mg; 5 mg |
| NY-ESO-1 94-102 (HLA-B*35:01) (HLA-B*51:01) | EP11376_1 | 1 mg; 5 mg |
| NY-ESO-1_LAGE-2 91-101 (HLA-A*24:02) | EP11837_1 | 1 mg; 5 mg |
| NY-ESO1 Sub Peptide Pool (>95% HPLC) | LB01704 | 15 nmol/peptide |
| p53 (Y220C) | EP14526_1 | 1 mg; 5 mg |
| p53 103-111 (HLA-A*02:01) | EP11386_1 | 1 mg; 5 mg |
| p53 139-147 (HLA-A*02:01) | EP11390_1 | 1 mg; 5 mg |
| p53 149-157 (HLA-A*02:01) | EP11382_1 | 1 mg; 5 mg |
| p53 149–157 mutant (HLA-A*02:01) 150T | EP11383_1 | 1 mg; 5 mg |
| p53 187-197 (HLA-A*02:01) | EP11379_1 | 1 mg; 5 mg |
| p53 264-272 (HLA-A*0201) | EP05796_1 | 1 mg; 5 mg |
| p53 65-73 (HLA-A*02:01) | EP11381_1 | 1 mg; 5 mg |
| P60 217-225 (H-2Kd) | EP14993_1 | 1 mg; 5 mg |
| p60 449–457 (H-2Kd) | EP14995_1 | 1 mg; 5 mg |
| p60 476 - 484 (H-2Kd) | EP14994_1 | 1 mg; 5 mg |
| PAP 299-307 | EP10769_1 | 1 mg |
| PAP-3 11-19 (HLA-A*02:01) | EP11387_1 | 1 mg; 5 mg |
| PAP-3 135-143 (HLA-A*02:01) | EP11388_1 | 1 mg |
| PASD1 167-175 (HLA-A*02:01) | EP11391_1 | 1 mg; 5 mg |
| PASD1 39-48 (HLA-A*02:01) | EP11380_1 | 1 mg; 5 mg |
| PASD1 694-702 (HLA-A*02:01) | EP11389_1 | 1 mg; 5 mg |
| PPI 2-10 (HLA-A*02:01) | EP07915_1 | 1 mg; 5 mg |
| PRAME 100-108 (HLA-A*02:01) | EP05802_1 | 1 mg; 5 mg |
| PRAME 242-251 (HLA-A*3) | EP14932_1 | 1 mg; 5 mg |
| PRAME 300–309 (HLA-A*02:01) | EP11397_1 | 1 mg; 5 mg |
| PRAME 301-309 (HLA-A*24) | EP11836_1 | 1 mg; 5 mg |
| PRAME 425-433 (HLA-A*02:01) | EP08114_1 | 1 mg |
| Prominin1 744-752 (HLA-A*02:01) | EP11398_1 | 1 mg; 5 mg |
| PSCA 105-113 (HLA-A*02:01) | EP11400_1 | 1 mg; 5 mg |
| PSCA 14-22 (HLA-A*02:01) | EP11401_1 | 1 mg; 5 mg |
| PSCA 44-51 (51A) (HLA-A*02:01) | EP11402_1 | 1 mg; 5 mg |
| PSM P2 (prostate) (HLA-A*02:01) | EP11403_1 | 1 mg; 5 mg |
| PSMA 178-186 (HLA-A*24:02) | EP12199_1 | 1 mg; 5 mg |
| PSMA 227-235 (HLA-A*24:02) | EP12198_1 | 1 mg; 5 mg |
| PSMA 27-38 (HLA-A*02:01) | EP11406_1 | 1 mg; 5 mg |
| PSMA 441-450 (HLA-A*02:01) | EP12197_1 | 1 mg; 5 mg |
| PSMA 624-632 (HLA-A*24:02) | EP12200_1 | 1 mg; 5 mg |
| PSMA 663-671 (HLA-A*02:01) | EP11404_1 | 1 mg |
| PSMA 85-93 (HLA-A*02:01) | EP11405_1 | 1 mg |
| PSMA/PSM-P1 4-12 (HLA-A*02:01) | EP11407_1 | 1 mg; 5 mg |
| RHAMM 165-173 (HLA-A*02:01) | EP07605_1 | 1 mg; 5 mg |
| SART3 309-317 (HLA-A*02:01) | EP11417_1 | 1 mg; 5 mg |
| Survivin 3A 18-27 mutant (HLA-A*03:01) 27K | EP11425_1 | 1 mg; 5 mg |
| Survivin 3a 51-59 mutant (HLA-B*35:01) 59Y | EP11426_1 | 1 mg; 5 mg |
| Survivin 3A 96-104 (HLA-A*02:01) | EP11424_1 | 1 mg; 5 mg |
| Survivin 47-56 (Y10)(HLA-A*01:01) | EP12187_1 | 1 mg; 5 mg |
| Survivin 5-14 (HLA-A*02:01) | EP07913_1 | 1 mg; 5 mg |
| Survivin 53-62 (HLA-A*11:01) | EP12188_1 | 1 mg; 5 mg |
| Survivin 80-88 (HLA-A*24:02) | EP11423_1 | 1 mg; 5 mg |
| Survivin 93–101 mutant (HLA-A*01:01) 94T | EP11421_1 | 1 mg; 5 mg |
| Survivin 95-104 (HLA-A*02:01) | EP07873_1 | 1 mg; 5 mg |
| Survivin 96-104 (HLA-A*02:01) | EP11422_1 | 1 mg; 5 mg |
| TGF-b 131-139 (HLA-A*02:01) | EP11436_1 | 1 mg; 5 mg |
| topII 828-836 (HLA-A*02:01) | EP11437_1 | 1 mg; 5 mg |
| TRAG3 4-12 (HLA-A*02:01) | EP11440_1 | 1 mg; 5 mg |
| TRAG3 57-66 (HLA-A*02:01) | EP11441_1 | 1 mg; 5 mg |
| TRP1 113-126 Mouse Tyrp2/gp75 | EP14041_1 | 1 mg; 5 mg |
| Trp2 180-188 | EP02373_1 | 1 mg; 5 mg |
| TRP2 181-190 (HLA-A*01:01) | EP12156_1 | 1 mg; 5 mg |
| TTK-567 (HLA-A*24:02) | EP11442_1 | 1 mg; 5 mg |
| Tyrosinase 146-156 (HLA-A*01:01) | EP11444_1 | 1 mg |
| Tyrosinase 206-214 (HLA-A*24:02) | EP11446_1 | 1 mg; 5 mg |
| Tyrosinase 208-216 (HLA-B*07:02) | EP11447_1 | 1 mg; 5 mg |
| Tyrosinase 243-251 mutant (HLA-A*01:01) 244S | EP11443_1 | 1 mg; 5 mg |
| Tyrosinase 369-377 mutant (HLA-A*02:01) 371D | EP05805_1 | 1 mg |
| Tyrosinase 425-434 (HLA-A*03:01) (HLA-A*11:01) | EP11445_1 | 1 mg; 5 mg |
| USP9Y (HLA-A*01:01) | EP11448_1 | 1 mg; 5 mg |
| Uty (H-2 Db) | EP07876_1 | 1 mg; 5 mg |
| Uty 566–573 (HLA-B*08:01) | EP11439_1 | 1 mg; 5 mg |
| VP1 14-22 (HLA-B*07:02) | EP11458_1 | 1 mg; 5 mg |
| VP1 182-190 (HLA-B*07:02) | EP11461_1 | 1 mg; 5 mg |
| VP1 2-10 (HLA-B*07:02) | EP11459_1 | 1 mg; 5 mg |
| VP1 252-260 (HLA-B*07:02) | EP11460_1 | 1 mg; 5 mg |
| WT1 126-134 (HLA-A*02:01) | EP07866_1 | 1 mg; 5 mg |
| WT1 126-134 mutant (HLA-A*02:01) 126Y | EP12631_1 | 1 mg; 5 mg |
| WT1 187-195 (HLA-A*02:01) | EP11468_1 | 1 mg |
| WT1 235-243 (HLA-A*24:02) | EP07872_1 | 1 mg; 5 mg |
| WT1 235–243 mutant (HLA-A*24:02) 236Y | EP11470_1 | 1 mg; 5 mg |
| WT1 317–327 (HLA-A*01:01) | EP11465_1 | 1 mg |
| WT1 37-45 (HLA-A*02:01) | EP11469_1 | 1 mg; 5 mg |
| [Ala8] - Humanin, [Ala8] - HN, Shna | EP09923_1 | 1 mg; 5 mg |
| [alpha]-Bag Cell Peptide (1 - 7) | EP09930_1 | 1 mg; 5 mg |
| [alpha]-Bag Cell Peptide (1 - 8) | EP09931_1 | 1 mg; 5 mg |
| [alpha]-Bag Cell Peptide (1 - 9) | EP09932_1 | 1 mg; 5 mg |
| beta-Amyloid (1-11) | EP10014_1 | 1 mg; 5 mg |
| [beta]-Amyloid (1-14) | EP10016_1 | 1 mg; 5 mg |
| [beta]-Amyloid (1-15) | EP10022_1 | 1 mg; 5 mg |
| [beta]-Amyloid (1-16) | EP10023_1 | 1 mg; 5 mg |
| [beta]-Amyloid (1-28) | EP10027_1 | 1 mg; 5 mg |
| [beta]-Amyloid (1-39) | EP10043_1 | 1 mg; 5 mg |
| [beta]-Amyloid (1-40), rat | EP10059_1 | 1 mg; 5 mg |
| [beta]-Amyloid (10-35) | EP10012_1 | 1 mg; 5 mg |
| beta-Amyloid (11-22) | EP10015_1 | 1 mg; 5 mg |
| [beta]-Amyloid (12-28) | EP10025_1 | 1 mg; 5 mg |
| [beta]-Amyloid (13-27) | EP10028_1 | 1 mg; 5 mg |
| [beta]-Amyloid (16-23) | EP10048_1 | 1 mg; 5 mg |
| [beta]-Amyloid (22-35) | EP10054_1 | 1 mg; 5 mg |
| [beta]-Casomorphin (1-7), bovine | EP10086_1 | 1 mg; 5 mg |
| Aquaporin-4, human Peptide Pool | LB02139 | 15 nmol/peptide |
| beta-Amyloid (11-40) | EP10013_1 | 1 mg; 5 mg |
| EBV (EBNA-3a) Peptide Pool | LB01361 | 15 nmol/peptide |
| GAD65 113-132 (DRB1*04:01) | EP14433_1 | 1 mg |
| GAD65 265-284 (DRB1*04:01) | EP14434_1 | 1 mg; 5 mg |
| GAD65 114-123 (HLA-A*02:01) | EP11177_1 | 1 mg; 5 mg |
| GAD65 114–122 (HLA-A*02:01) | EP11176_1 | 1 mg; 5 mg |
| GAD65 274-286 (DRB1*04:01) | EP14432_1 | 1 mg; 5 mg |
| GAD65 555-567 (DRB1*04:01) | EP14431_1 | 1 mg; 5 mg |
| gB2 498-505 (H-2 Kb) | EP10788_1 | 1 mg; 5 mg |
| Glutamate decarboxylase 2 / GAD2 / GAD65 Peptide Pool | LB02128 | 15 nmol/peptide |
| Glutamic acid decarboxylase / GAD65 Peptide Pool | LB02017 | 15 nmol/peptide |
| IAPP 5-13 (HLA-A*02:01) | EP11306_1 | 1 mg; 5 mg |
| Livin 175-184 (HLA-A*02:01) | EP11335_1 | 1 mg; 5 mg |
| MBP (1 - 11) mouse | EP09886_1 | 1 mg; 5 mg |
| MBP (1 - 11) mutant 4A | EP09887_5 | 1 mg; 5 mg |
| MBP (1 - 17) | EP09889_1 | 1 mg; 5 mg |
| MBP (1-11) human | EP09838_1 | 1 mg; 5 mg |
| MBP (1-20) | EP09890_1 | 1 mg; 5 mg |
| MBP (111 - 129) | EP09907_1 | 1 mg; 5 mg |
| MBP (131–155) | EP09908_1 | 1 mg; 5 mg |
| MBP (14 - 33) | EP09892_1 | 1 mg; 5 mg |
| MBP (146–170) | EP09909_1 | 1 mg; 5 mg |
| MBP (273-281), bovine, MBP (138-146), mouse | EP09910_1 | 1 mg; 5 mg |
| MBP (54-72) human | EP09839_1 | 1 mg; 5 mg |
| MBP (63–81) | EP09893_1 | 1 mg; 5 mg |
| MBP (65 - 75); Peptide S24 | EP09895_1 | 1 mg; 5 mg |
| MBP (68–86) | EP09896_1 | 1 mg; 5 mg |
| MBP (69-88) | EP09897_1 | 1 mg; 5 mg |
| MBP (79 - 87) | EP09900_1 | 1 mg; 5 mg |
| MBP (84 - 105) | EP09902_1 | 1 mg; 5 mg |
| MBP (84 - 97) | EP09901_1 | 1 mg; 5 mg |
| MBP (87 - 99), human | EP09903_1 | 1 mg; 5 mg |
| MBP (92 - 111) | EP09906_1 | 1 mg; 5 mg |
| MBP Isoform 1, human Peptide Pool | LB02135 | 15 nmol/peptide |
| MBP Isoform 5, human Peptide Pool | LB02138 | 15 nmol/peptide |
| MOBP 16 - 37, mouse | EP09885_1 | 1 mg; 5 mg |
| MOG (human) Peptide Pool | LB01852 | 15 nmol/peptide |
| MOG 1 - 21, rat | EP09855_1 | 1 mg; 5 mg |
| MOG 1 - 26, human | EP09856_1 | 1 mg; 5 mg |
| MOG 101 - 108, rat | EP09883_1 | 1 mg; 5 mg |
| MOG 101 - 120, human, mouse | EP09884_1 | 1 mg; 5 mg |
| MOG 14 - 39, human | EP09859_1 | 1 mg; 5 mg |
| MOG 183-191 | EP09836_1 | 1 mg; 5 mg |
| MOG 27 - 50, human | EP09860_1 | 1 mg; 5 mg |
| MOG 35 - 51 | EP09861_1 | 1 mg; 5 mg |
| MOG 35 - 53 | EP09863_1 | 1 mg |
| MOG 35-52 | EP09862_1 | 1 mg; 5 mg |
| MOG 35-55 | EP02030_1 | 1 mg |
| MOG 35-55 human | EP09833_1 | 1 mg; 5 mg |
| MOG 37-50 | EP12109_1 | 1 mg |
| MOG 37–54, mouse, rat | EP09864_1 | 1 mg; 5 mg |
| MOG 38 - 55 | EP09866_1 | 1 mg; 5 mg |
| MOG 38 - 60, human | EP09867_1 | 1 mg; 5 mg |
| MOG 38-53 | EP09865_1 | 1 mg; 5 mg |
| MOG 40-54 | EP09868_1 | 1 mg; 5 mg |
| MOG 40-55 | EP09869_1 | 1 mg; 5 mg |
| MOG 41-54 | EP09870_1 | 1 mg; 5 mg |
| MOG 42 - 54 | EP09871_1 | 1 mg; 5 mg |
| MOG 43-54 | EP09872_1 | 1 mg; 5 mg |
| MOG 45 - 54 | EP09873_1 | 1 mg; 5 mg |
| MOG 46 - 54 | EP09874_1 | 1 mg; 5 mg |
| MOG 50 - 74, human | EP09875_1 | 1 mg; 5 mg |
| MOG 67 - 87, rat | EP09877_1 | 1 mg; 5 mg |
| MOG 71 - 90, mouse | EP09876_1 | 1 mg |
| MOG 76 - 100, human | EP09878_1 | 1 mg; 5 mg |
| MOG 8 - 21 | EP09857_1 | 1 mg; 5 mg |
| MOG 8 - 22, rat | EP09858_1 | 1 mg; 5 mg |
| MOG 89 - 113, human | EP09879_1 | 1 mg; 5 mg |
| MOG 91 - 108, rat | EP09837_1 | 1 mg; 5 mg |
| MOG 91 - 114, rat | EP09880_1 | 1 mg; 5 mg |
| MOG 92-106 | EP09834_1 | 1 mg; 5 mg |
| MOG 94 - 110, human | EP09881_1 | 1 mg; 5 mg |
| MOG 96 - 108, human | EP09882_1 | 1 mg; 5 mg |
| MOG 97-108 | EP09835_1 | 1 mg; 5 mg |
| Myelin basic protein 110-118 (HLA-A*02:01) | EP11367_1 | 1 mg |
| PLP (139-151) | EP09840_1 | 1 mg; 5 mg |
| PLP (139-151) mutant 140S | EP09915_1 | 1 mg; 5 mg |
| PLP (139-151) mutant 144A | EP09911_1 | 1 mg; 5 mg |
| PLP (178-191) | EP09841_1 | 1 mg |
| PLP (180 - 199) | EP09916_1 | 1 mg; 5 mg |
| PLP (190 - 209) | EP09917_1 | 1 mg; 5 mg |
| PLP (48 - 70) | EP09918_1 | 1 mg |
| PLP (56-70) | EP09919_1 | 1 mg; 5 mg |
| PLP (57-70) | EP09920_1 | 1 mg; 5 mg |
| PLP1, human Peptide Pool | LB02134 | 15 nmol/peptide |
| [Phe17] - Apelin | EP10199_1 | 1 mg; 5 mg |
| ACTH (1-39) (human) | EP10644_1 | 1 mg; 5 mg |
| ACTH (18-39) (human) | EP10600_1 | 1 mg; 5 mg |
| Ala13 - Apelin - 13 | EP09928_1 | 1 mg; 5 mg |
| CRGDS | EP08010_1 | 1 mg; 5 mg |
| Interferon gamma inducible protein (GILT) 30 27-35 (HLA-A*02:01) | EP11326_1 | 1 mg; 5 mg |
| Interleukin-22 human Peptide Pool | LB01971 | 15 nmol/peptide |
| Larazotide (AT-1001) | EP09074_1 | 1 mg; 5 mg |
| Nuf2 56–64 (HLA-A*24:02) | EP11373_1 | 1 mg; 5 mg |
| PLAC1 p31-39 (HLA-A*02:01) | EP11393_1 | 1 mg; 5 mg |
| [alpha]-Casein (90-95) | EP09933_1 | 1 mg; 5 mg |
| 3x FLAG Peptide | EP07918_1 | 1 mg; 5 mg |
| Alpha-crystallin B chain (human) Peptide Pool | LB02149 | 15 nmol/peptide |
| Arg9 | EP09843_1 | 1 mg; 5 mg |
| CDH3 807-816 (HLA-A*24:02) | EP11377_1 | 1 mg; 5 mg |
| CKS2 11-19 (HLA-C0702) | EP13049_1 | 1 mg; 5 mg |
| Coagulation factor VIII, human Peptide Pool | LB02146 | 15 nmol/peptide |
| CPIM 399–406 (H-2 Kb) | EP13089_1 | 1 mg; 5 mg |
| CyLoP-1 | EP09848_1 | 1 mg; 5 mg |
| DEAD box RNA helicase 355–363 (HLA-C*05:01) | EP14505_1 | 1 mg; 5 mg |
| ERBB2 HUMAN Peptide Pool (HER2) | LB02229 | 15 nmol/peptide |
| FLAG | EP01741_1 | 1 mg; 5 mg |
| HUMAN GKAP1 Peptide Pool | LB01675 | 15 nmol/peptide |
| P2X5a (HLA-B*07:02) | EP11378_1 | 1 mg; 5 mg |
